Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

419
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
419
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

1.0K
The pathophysiology of pneumonia involves the following steps:
1.0K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

269
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
269
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

2.0K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

407
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
407
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

671
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
671

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.

medRxiv : the preprint server for health sciences·2026
Same author

Resurgence of Tetanus-Reasons Why the Vaccine Remains Instrumental.

JAMA·2026
Same author

From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Vaccine and Treatment Evaluation Units: A Historical Perspective.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

What's Old Is New Again: Pertussis.

Pediatrics·2025
Same author

Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews.

Vaccine·2025
Same journal

Retraction of: Tracking Plasmodium knowlesi Through Fecal DNA for Monitoring Zoonotic Transmission in Wild Macaques Across Southeast and South Asia.

The Journal of infectious diseases·2026
Same journal

Can malaria induce loss of vaccine immunity.

The Journal of infectious diseases·2026
Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026
Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026
Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026
Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Oct 18, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K

Pertussis (Whooping Cough).

Michael D Decker1,2, Kathryn M Edwards2

  • 1Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

The Journal of Infectious Diseases
|September 30, 2021
PubMed
Summary
This summary is machine-generated.

Pertussis, a dangerous respiratory infection, is preventable with vaccines. Acellular pertussis vaccines are recommended for all ages, with crucial boosters during pregnancy to protect newborns.

Keywords:
pertussispertussis vaccinevaccine-preventable diseaseswhooping cough

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.4K

Related Experiment Videos

Last Updated: Oct 18, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.4K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Pertussis (whooping cough), caused by Bordetella pertussis, is a highly contagious respiratory infection posing significant risks, especially to young infants.
  • While historically prevalent, widespread vaccination has dramatically reduced pertussis incidence.
  • Concerns regarding adverse reactions to whole-cell vaccines led to the development and adoption of less reactogenic acellular pertussis vaccines.

Purpose of the Study:

  • To summarize the epidemiology and current vaccination strategies for pertussis.
  • To highlight the importance of acellular pertussis vaccines in public health.
  • To address the growing concern of waning vaccine immunity and the need for new vaccine development.

Main Methods:

  • Review of epidemiological data on pertussis incidence and severity.
  • Analysis of vaccine efficacy and safety profiles of whole-cell versus acellular pertussis vaccines.
  • Examination of current vaccination schedules and recommendations, including infant, childhood, adolescent, and adult/pregnancy boosters.
  • Discussion of emerging challenges, such as waning immunity and the evaluation of novel vaccine candidates.

Main Results:

  • Acellular pertussis vaccines have significantly decreased disease burden compared to whole-cell vaccines.
  • Routine immunization schedules, including boosters during pregnancy, are critical for protecting infants and controlling outbreaks.
  • Waning immunity over time is a recognized issue, necessitating ongoing research into improved and longer-lasting pertussis vaccines.

Conclusions:

  • Acellular pertussis vaccines are a cornerstone of current pertussis prevention strategies.
  • Maternal immunization and timely boosters are essential for safeguarding vulnerable populations, particularly newborns.
  • The development of new pertussis vaccines is crucial to overcome challenges related to waning immunity and ensure sustained protection.